Aurora Cannabis Inc (TSX:ACB) (NYSE:ACB) is pushing for profits by cutting its costs … is the stock a buy? Andrew Button ❯ Published February 9, 2020 5:00 pm EST ACB ACB You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services.
Full Answer
What are the best cannabis stocks to buy?
open up to adult-use marijuana. Verano also has a nice gross profit margin at 62%. It may be the best bet of the three for long-term growth and it certainly is an up-and-coming multistate operator, but the relative newness of the company as a public stock ...
What is the best cannabis stock?
“Non-alcoholic cannabis beverages dominate the market and are also expected to register strong growth, mainly supported by growing demand from female and new customers, especially millennials, and also rising interest in wellness drinks among customers.
Is Motley Fool worth it?
The company has so much cash that it’s been rewarding shareholders by repurchasing many shares. During its third quarter, it bought back more than $14 billion worth of its stock, and announced a $50 billion increase to its share repurchase program. (The Motley Fool owns shares of and has recommended Meta Platforms.
Is the Motley Fool publicly owned?
The Motley Fool is a private financial and investing advice company based in Alexandria, Virginia. It was founded in July 1993 by co-chairmen and brothers David Gardner and Tom Gardner, and Erik Rydholm, who has since left the company. Its main business is online subscription services with investing recommendations, stock research, and analysis.
See more
These pot stocks offer a solid path to strong returns that Dogecoin can't
Could Dogecoin ( DOGE -1.64% ) make the comeback of all comebacks? Maybe, but I wouldn't necessarily bank on it. Even if the popular cryptocurrency's rebound picks up additional momentum, any gains could evaporate quickly.
Ayr Wellness
Ayr Wellness ( AYRW.F -3.98% ) ranks as one of the fastest-growing multistate cannabis operators in the U.S. The company reported 74% year-over-year revenue growth in the first quarter of 2021.
NYSE: IIPR
One key reason for Ayr's tremendous growth is its aggressive acquisition strategy. In February, the company completed the acquisition of Liberty Health Sciences, giving it a major presence in Florida's medical cannabis market. Near the end of Q1, Ayr completed acquisitions in Arizona and Ohio.
Cresco Labs
Cresco Labs ( CRLBF -3.28% ) stands out as another multistate cannabis operator that's grown tremendously through acquisitions. The company's buyout of Origin House last year vaulted it instantly into a leading position in California.
Innovative Industrial Properties
Innovative Industrial Properties ( IIPR 4.00% ) provides something to investors that Dogecoin and few other cannabis stocks can offer -- a dividend every quarter. As a real estate investment trust ( REIT ), the company must distribute at least 90% of its taxable income to shareholders in the form of dividends.
Premium Investing Services
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
A Smith Falls-based cannabis giant
Canopy Growth (TSX:WEED) (NYSE:CGC) is a dual-listed cannabis giant in North America which is well positioned to take advantage of the U.S. legalization wave. It’s over 70% down from both, its all-time high in Sept. 2018 and its recent 2021 peak. But the company still maintains a market capitalization of about $6.9 billion.
A Toronto-based cannabis company
Another cannabis company that’s currently trading at a fraction of its former glory (about one-fourth the price) is Cronos Group (TSX:CRON) (NASDAQ:CRON). It’s also dual-listed, which means that it might also see a sizeable growth in the investor pool once the cannabis legalization wave sweeps the U.S.
A Nanaimo-based cannabis company
Tilray (TSX:TLRY) (NASDAQ:TLRY) became the largest cannabis company by revenue earlier this year by merging with another major player in the industry — i.e., Aphria. The new Tilray is a giant, although neither the market capitalization nor the stock currently reflects Tilray’s newfound power.
Foolish takeaway
The companies might not be as cheap as they are ever going to be. If the U.S. cannabis legalization wave takes longer to sweep the market, the companies might keep going down at a steady pace. But once the news break, the sector might see a lot of investor activity.
Stock Advisor Canada Returns
Returns since inception, October 2013. Current as of February 26, 2022.
United States legalization looks unlikely: Should you bail on this cannabis stock?
Canopy Growth (TSX:WEED) (NYSE:CGC) has maintained its position as one of the top producers in Canada. Shares of this cannabis stock have plunged 66% in 2021 as of close on December 20.
Stock Advisor Canada Returns
Returns since inception, October 2013. Current as of February 24, 2022.
The grass is certainly not greener with this cannabis trio
A Fool since 2010, and a graduate from UC San Diego with a B.A. in Economics, Sean specializes in the healthcare sector and investment planning. You'll often find him writing about Obamacare, marijuana, drug and device development, Social Security, taxes, retirement issues and general macroeconomic topics of interest. Follow @AMCScam
Key Points
Marijuana should be one of the fastest-growing industries this decade, but not every pot stock can be a winner.
Aurora Cannabis
Aurora Cannabis ( NASDAQ:ACB) was once the most-held stock on online investing app Robinhood. It had 15 production facilities, was expected to peak at well north of 600,000 kilos of annual production, and sported a market cap of nearly $10 billion. Nowadays, it's a regular resident of the pot stocks to avoid column.
Cronos Group
Another pot stock that should be given the cold shoulder by investors in August is Cronos Group ( NASDAQ:CRON).
Sundial Growers
The third pot stock to avoid like the plague in August is a frequent visitor to this monthly list: Sundial Growers ( NASDAQ:SNDL).
A Smith Falls-based Cannabis Giant
- Canopy Growth (TSX:WEED)(NYSE:CGC) is a dual-listed cannabis giant in North America which is well positioned to take advantage of the U.S. legalization wave. It’s over 70% down from both, its all-time high in Sept. 2018 and its recent 2021 peak. But the company still maintains a market capitalization of about $6.9 billion. One of Canopy’s major strengths is the wealth of brands und…
A Toronto-Based Cannabis Company
- Another cannabis company that’s currently trading at a fraction of its former glory (about one-fourth the price) is Cronos Group (TSX:CRON)(NASDAQ:CRON). It’s also dual-listed, which means that it might also see a sizeable growth in the investor pool once the cannabis legalization wave sweeps the U.S. and the market starts booming in most of North America. Cronos is more focus…
A Nanaimo-based Cannabis Company
- Tilray (TSX:TLRY)(NASDAQ:TLRY) became the largest cannabis companyby revenue earlier this year by merging with another major player in the industry — i.e., Aphria. The new Tilray is a giant, although neither the market capitalization nor the stock currently reflects Tilray’s newfound power. The market cap is at $5.24 billion, and the stock is down ...
Foolish Takeaway
- The companies might not be as cheap as they are ever going to be. If the U.S. cannabis legalization wave takes longer to sweep the market, the companies might keep going down at a steady pace. But once the news break, the sector might see a lot of investor activity. You might want to consider buying these potentially explosive growth stocksnow before they reach new hei…